Addition of Lenalidomide to Rituximab, Ifosfamide, Carboplatin, Etoposide (RICER) in First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma

British Journal of Haematology - United Kingdom
doi 10.1111/bjh.12846
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Wiley

Related search

Molecular Landscape of Relapse/Refractory Diffuse Large B-Cell Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

A Phase Ii Study of Lenalidomide and Rituximab (R²) Combination in Patients With High-Risk Refractory/Relapsed Diffuse Large B-Cell Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Regression of Refractory Intraocular Large B-Cell Lymphoma With Lenalidomide Monotherapy

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2011English

Bendamustine Combined With Rituximab for Patients With Relapsed or Refractory Diffuse Large B Cell Lymphoma

Annals of Hematology
MedicineHematology
2013English

A Multicentre Study of Primary Breast Diffuse Large B-Cell Lymphoma in the Rituximab Era

British Journal of Haematology
Hematology
2014English

Lenalidomide in Diffuse Large B-Cell Lymphomas

Advances in Hematology
Hematology
2012English

Primary Diffuse Large B-Cell Lymphoma of the Mandible

Autopsy and Case Reports
2019English

Epiphyseal Primary Diffuse Large B-Cell Lymphoma of Bone

Case Reports in Pathology
2018English

Primary Diffuse Large B-Cell Lymphoma of the Bladder

Internal Medicine
Internal MedicineMedicine
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy